About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

WeChat Quit Coach Pilot Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05130788

WeChat Quit Coach Pilot Study

The study team will develop and assess the feasibility and acceptability of a WeChat-based peer-group mobile messaging smoking cessation intervention targeting Chinese immigrant smokers in New York Ci...

Lead sponsor: NYU Langone Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

NYU Langone Health

Collaborators

Asian Americans for Equality
Chinese American Planning Council
National Institute on Minority Health and Health Disparities (NIMHD)

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Aim 2:
•Age 18-80 years
•Chinese immigrant
•Have smoked at least 100 cigarettes in a lifetime
•Smoke ≥3 days per week
•Be somewhat interested in quitting smoking
•Has a Smartphone
•Current WeChat user who uses WeChat on ≥3 days per week
•Live in NYC
•Can read and speak Chinese
•Be able to provide consent
•Aim 3:
•Age 18 years or above
•Chinese immigrant
•Have smoked at least 100 cigarettes in a lifetime
•Smoke ≥1 days per week
•Current WeChat user who uses WeChat on ≥3 days per week
•Can read and speak Chinese

Exclusion Criteria

•Aim 2:
•Current participation in other smoking cessation treatment program(s)
•Be pregnant or breastfeeding
•Aim 3:
•Current participation in other smoking cessation treatment program(s)
•Be pregnant or breastfeeding
•Having a household member who has enrolled in this study

Related studies

Phone Enabled Implementation of Cessation Support

NCT05628389 · Smoking Cessation

Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy

NCT06948058 · Smoking Cessation, Obesity and Obesity-related Medical Conditions

RECRUITINGPhase 2/3

Empowering Cessation ACS South Region

NCT06820034 · Smoking Cessation

Trauma-Informed Care for Smoking Cessation for Pregnancy

NCT07129590 · Smoking Cessation, Tobacco Smoking, and more

RECRUITINGPhase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 9, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment150

Start dateFeb 2022

Last updatedApr 9, 2025

Condition

Smoking Cessation

Locations shown

NYU Langone Health

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions